Bayesian Capital Management’s Avient AVNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,500
Closed -$210K 539
2025
Q2
$210K Buy
+6,500
New +$225K 0.03% 453
2018
Q1
Sell
-9,500
Closed -$413K 583
2017
Q4
$413K Buy
+9,500
New +$417K 0.08% 359
2017
Q3
Sell
-10,500
Closed -$407K 468
2017
Q2
$407K Buy
10,500
+2,690
+34% +$100K 0.15% 222
2017
Q1
$266K Buy
+7,810
New +$262K 0.13% 281
2016
Q3
Sell
-6,426
Closed -$226K 357
2016
Q2
$226K Buy
+6,426
New +$227K 0.14% 295

Other funds holding AVNT

Bayesian Capital Management's AVNT Position: Q3 2025 in Review

Bayesian Capital Management sold out of Avient (AVNT) in Q3 2025, closing a stake of 6,500 shares — an estimated $210K sold.

Bayesian Capital Management first reported a position in AVNT in Q2 2016 and held it in 5 quarters. The position peaked at $413K in Q4 2017. 322 funds tracked by Wall St. Rank hold AVNT as of Q3 2025.

  • Bayesian Capital Management reported no remaining Avient position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 6,500 Avient shares in Q3 2025, an estimated $210K.
  • Bayesian Capital Management first reported a position in Avient in Q2 2016 and held it in 5 quarters.
  • Bayesian Capital Management's Avient position peaked at $413K in Q4 2017.
  • 322 funds tracked by Wall St. Rank held Avient as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.